[ad_1] RT @MDPIpharma: #MDPIPharmaceutics š Suprachoroidal targeting of chorioretina in 4 trials: CLS-AX – AMD, RGXā314 – AMD/DR & AUā011 – choroiā¦ [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @RetinalPhys: The Latest on Drug Delivery in the Suprachoroidal Space: Maximize treatment effect and minimize exposure to other ocular tā¦ [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Congrats to our colleagues & team, who had numerous presentations at this year’s ARVO on suprachoroidal space delivery platform, gene therapy, CLS-TA, & treatment burden and unmet needs with current anti-VEGF-A therapies…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Retinal OCT for Clinicians https://t.co/rwa3BS3Lew via @YouTube [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] RT @RetinalPhys: Our most read article from the April issue is “Retinal OCT Biomarkers for Clinicians and Clinical Researchers.” @ThomasCiuā¦ [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.